May 2022

Climate concerns have been an ongoing topic that we will also address in May's issue. In other news, we will explore how new data on vaginal microbe compositions and their functions could impact the way we treat related conditions. We’ll also take a look at how e-commerce can actually cut insulin costs for patients, and how this would affect payers and manufacturers.


We’ll also look at how pharma can keep the “feel-good” sentiments it garnered pre-pandemic, alive. Whilst the success stories of Pfizer and Moderna increased people’s trust in pharma during the pandemic, some hiccups in Covid-19 vaccines like with J&J and AstraZeneca's jabs, caused the positive outlook to fall, it has been reported.

EDITORIAL

Editor | Jennifer C Smith-Parker

Writers | Darcy Jimenez, Manasi Vaidya, William Newton​​​​​​​, Adam Zamecnik.
Magazine Designer | Maria Gimenez

Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Filipe Costa, Martina Labaiova, Dimeji Akinkuolie, Will Ingham
Lead Designer | John Hammond 

Publisher | Susanne Hauner
Digital Publishing Director | Duncan West

Advertising

Sales Manager | Nimai Amin

+44 (0) 207 936 6453

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Copyright 2022 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.